Search

Humana Inc

Lezárt

SzektorEgészségügy

401.36 -1.14

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

397.33

Maximum

406.51

Fő mutatók

By Trading Economics

Bevétel

-491M

693M

Értékesítés

1.2B

41B

P/E

Szektor átlag

36.498

56.659

Egy részvényre jutó nyereség

7.61

Osztalékhozam

0.92

Profit margin

1.696

Munkavállalók

67,060

EBITDA

-658M

1.3B

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+7.05% upside

Osztalékok

By Acuity

Osztalékhozam

Szektor átlag

0.92%

2.18%

Következő eredményjelentés

2026. nov. 4.

Következő osztalékfizetési dátum

2026. nov. 27.

Következő korábbi osztalék dátum

2026. szept. 30.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-724M

46B

Előző nyitás

402.5

Előző zárás

401.36

Hangulat hírek alapján

By Acuity

26%

74%

58 / 339 Rangsor szerint Healthcare

Humana Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. szept. 3. 20:07 UTC

News

Humana Inc has earned the 2026 Great Place To Work Certification, contributing to positive investor sentiment as shares advance during Thursday's session.

2026. szept. 2. 20:08 UTC

News

Humana Inc. shares are advancing as the company declared a quarterly cash dividend of $0.885 per share, payable on November 27, 2026.

2026. szept. 1. 20:01 UTC

News
Event

Humana Inc. reaffirmed its fiscal year 2026 guidance, projecting at least $9 adjusted EPS, contributing to a positive market reaction and higher shares.

2026. aug. 27. 19:46 UTC

News

Humana has partnered with DaVita to enhance care for Medicare Advantage members with chronic kidney disease. Shares are advancing amid positive market sentiment.

2026. aug. 26. 20:08 UTC

Humana Inc shares are higher today amid mixed market performance and inflation data showing a slight consumer price increase in July.

2026. aug. 25. 22:02 UTC

Humana Inc shares are higher in after-market hours, rebounding from session lows despite a broader market pullback and declining consumer confidence.

2026. aug. 24. 20:06 UTC

News

Wolfe Research raised Humana's price target to $450, maintaining an Outperform rating. Shares are higher today, reflecting positive sentiment from the upgrade.

2026. aug. 21. 19:31 UTC

Humana Inc. shares are advancing, reflecting a broader rebound in U.S. stocks amid ongoing economic uncertainties. They pulled back earlier but regained momentum.

2026. aug. 20. 19:36 UTC

News

Humana Inc. appointed Dr. Shantanu Nundy as Chief Medical Officer, effective August 31. Shares are higher since Wednesday's close amid this leadership change.

2026. aug. 19. 19:51 UTC

News

Humana Inc. shares are lower, impacted by a significant decline in the Managed Health Care sub-sector. The company continues expanding its home-based care initiative.

2026. aug. 18. 19:16 UTC

Humana Inc shares are lower amid broader market weakness and rising U.S. Treasury yields, despite an earlier recovery during the session.

2026. aug. 14. 19:46 UTC

Humana Inc shares are higher today, reflecting a broader positive market trend despite recent negative sentiment following a decline in U.S. retail sales.

2026. aug. 12. 20:01 UTC

Humana Inc shares are higher during Wednesday's session, continuing an upward trend since Tuesday. The move occurs amid mixed macroeconomic signals and geopolitical tensions.

2026. aug. 10. 19:16 UTC

News

Humana shares advance as JPMorgan raises price target to $393.

2026. aug. 7. 20:03 UTC

Humana Inc shares are higher today, continuing strong momentum from recent sessions. No specific company news was identified to explain this price action.

2026. aug. 6. 23:02 UTC

Humana Inc shares are lower in after-market trading, continuing a decline since Thursday's close and remaining below their 20-day moving average.

2026. aug. 5. 19:56 UTC

News
Social Media

Morgan Stanley upgraded Humana Inc to Equal-Weight and raised its price target to $370. Shares are gaining amid positive analyst sentiment and service area expansion.

2026. aug. 4. 20:04 UTC

News

Humana Inc is under investigation by Bronstein, Gewirtz & Grossman, LLC, raising concerns among investors and contributing to a decline in shares.

2026. aug. 3. 22:26 UTC

Humana Inc. shares are higher in after-market trading, continuing gains since Monday's close, though still below the 20-day moving average.

2026. júl. 31. 19:36 UTC

News

Humana Inc shares are lower today amid broader weakness in the Managed Health Care sector, despite price target increases from TD Cowen and Barclays.

2026. júl. 30. 18:36 UTC

News

Upgrades from Guggenheim, Evercore ISI boost Humana investor sentiment.

2026. júl. 29. 23:06 UTC

Humana Inc shares are trading lower in after-market hours, continuing a decline below the 20-day moving average and near the one-month trading range's lower end.

2026. júl. 28. 23:16 UTC

News
Social Media

Humana shares decline in after-market trading following the end of a Medicare drug subsidy program, which may raise costs for seniors and pressure insurers.

2026. júl. 27. 19:16 UTC

News

Humana Inc. shares are lower as Schubert Jonckheer & Kolbe LLP investigates potential false statements about healthcare costs amid ongoing securities fraud claims.

2026. júl. 24. 19:31 UTC

Humana Inc's shares are lower today amid broader weakness in the Managed Health Care sub-sector, reversing a trend of higher daily closes since Thursday.

2026. júl. 22. 19:26 UTC

Humana Inc. shares are lower today amid notable volatility and a mixed performance in global markets, with U.S. indices generally declining.

2026. júl. 20. 18:46 UTC

Humana Inc's shares are higher today, reflecting a slight increase since Friday's close. The stock is near the upper end of its one-month trading range.

Társak összehasonlítása

Árváltozás

Humana Inc Előrejelzés

Célár

By TipRanks

7.05% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 429.86 USD  7.05%

Magas 624 USD

Alacsony 280 USD

23 Wall Street elemző 12 hónapos célárain alapulva a(z)Humana Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

23 ratings

11

Vétel

11

Tartás

1

Eladás

Hangulat

By Acuity

58 / 339 Rangsor szerint Egészségügy

Hangulat hírek alapján

Bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag feletti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Humana Inc

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
help-icon Live chat